Sfoglia per AUTORE
CALCAGNO A
Collezione ASL Città di Torino

  

Items : 153

Real-life reliability of plasma pTau181, A?(42)/A?(40), and pTau181/A?(42) measured by Lumipulse G600II in predicting cerebrospinal fluid amyloid status. in Journal of Alzheimer's disease : JAD / J Alzheimers Dis. 2025 Jan;103(1):305-315. doi: 10.1177/13872877241300315. Epub 2024 Dec 3.
2025
AO Cuneo
ASL Alessandria
ASL Cuneo 1
ASL Città di Torino

Bozzali M; Lopiano L; Ferrandi D; Rainero I; Bonzanino M; De Mattei M; Barra M; Godi L; Rota E; Bongioanni MR; Rosso M; Coletti Moja M; Calcagno A; Capobianco M; Secci V; Murgioni A; Bagatin A; Atzori C; Angeloro DP; Imperiale D;

The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognition. in bioRxiv : the preprint server for biology / bioRxiv [Preprint]. 2025 Feb 28:2025.02.28.640732. doi: 10.1101/2025.02.28.640732.
2025
ASL Città di Torino

Trunfio M; Scutari R; Fox V; Vuaran E; Dastgheyb RM; Fini V; Granaglia A; Balbo F; Tortarolo D; Bonora S; Perno CF; Di Perri G; Alteri C; Calcagno A;

Doxycycline Post-exposure Prophylaxis and Sexually Transmitted Infections in Italy, 2023. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2025 Feb 24;80(2):476-477. doi: 10.1093/cid/ciae219.
2025
ASL Città di Torino

Lucchini A; Ghisetti V; Agosta D; Del Re S; Delmonte S; Tutone M; Calcagno A;

2025
ASL Asti
ASL Città di Torino

Codecasa L; Calcagno A; Blasi F; Spotti M; Gori A; Cinnirella G; Venuti F; Gaviraghi A; Lupia T; Stroffolini G; Aliberti S;

TB outpatient care in a high-income, low-incidence country. in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease / Int J Tuberc Lung Dis. 2024 Oct 1;28(10):513-515. doi: 10.5588/ijtld.24.0059.
2024
ASL Città di Torino

Riccardi N; Monari C; Antonello RM; Saderi L; Occhineri S; Pontarelli A; Zucchi P; Buonsenso D; Falbo E; Faverio P; Aliberti S; Parrella R; Falcone M; Besozzi G; Calcagno A; Goletti D; Gualano G; Sotgiu G; Tadolini M; Codecasa L;

Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS T cells and inflammation. in The Journal of clinical investigation / J Clin Invest. 2024 Oct 1;134(19):e176358. doi: 10.1172/JCI176358.
2024
ASL Città di Torino

Price RW; Cinque P; Gisslen M; Spudich S; Vercesi R; Zhou S; Calcagno A; Trunfio M; Dravid A; Kincer LP; Joseph SB;

Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):180-191. doi: 10.1097/QAI.0000000000003480.
2024
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S; Trentalange A; Giaccone C; Trunfio M; Noce G; Ghisetti V; Tettoni MC; Nigra M; Guastamacchia G; Stroffolini G; Pirriatore V; Barco A; Vai D; Lazzaro A;

Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. in Brain : a journal of neurology / Brain. 2024 Nov 4;147(11):3742-3750. doi: 10.1093/brain/awae271.
2024
ASL Città di Torino

Gulminetti R; Ripamonti D; Muscatello A; Antinori A; Gabrieli A; Rusconi S; Bruzzesi E; Trunfio M; Bernasconi D; Marchetti G; Cinque P; Cusato J; Calcagno A; Antonucci M; Nozza S;

Dual ?-lactams for the treatment of Mycobacterium abscessus: a review of the evidence and a call to act against an antibiotic nightmare. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2024 Nov 4;79(11):2731-2741. doi: 10.1093/jac/dkae288.
2024
ASL Città di Torino

Longo BM; Trunfio M; Calcagno A;

Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study. in AIDS and behavior / AIDS Behav. 2024 Nov;28(11):3643-3654. doi: 10.1007/s10461-024-04440-w. Epub 2024 Jul 30.
2024
ASL Città di Torino

Calcagno A; Letendre SL; Bonora S; Di Perri G; Cinnirella G; Imperiale D; Di Stefano A; Quarta C; Vuaran E; Vai D; Trunfio M;

Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV. in AIDS (London, England) / AIDS. 2024 Mar 15;38(4):477-486. doi: 10.1097/QAD.0000000000003775. Epub 2023 Nov 7.
2024
ASL Città di Torino
AOU Città della Salute di Torino

Calcagno A; Di Perri G; Letendre SL; Bonora S; Imperiale D; Cavallo R; Pittaluga F; Croce M; Trunfio M; Sacchi A; Vai D;

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study. in Infectious diseases and therapy / Infect Dis Ther. 2024 Mar;13(3):609-617. doi: 10.1007/s40121-024-00935-0. Epub 2024 Feb 19.
2024
ASL Città di Torino

Ambrosioni J; Díaz NA; Marzolini C; Dragovic G; Imaz A; Calcagno A; Luque S; Curran A; Troya J; Tuset M; Khoo S; Burger D; Cortés CP; Naous N; Molto J;

Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
ASL Città di Torino

D'Avolio A; Di Perri G; Bonora S; Trunfio M; Antonucci M; Marinaro L; Avataneo V; Mula J; Palermiti A; Manca A; Cusato J; Calcagno A;

2024
ASL Città di Torino

Palmieri F; Gori A; Falbo E; Mencarini J; Surace L; Pontali E; Gualano G; Russo A; Pirriatore V; Trezzi M; Di Biagio A; Riccardi N; Parrella R; Matteelli A; Tadolini M; Sarmati L; Coppola N; Calcagno A; Schiuma M; Lapadula G; Goletti D;

Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. doi: 10.1128/aac.00234-24. Epub 2024 May 24.
2024
ASL Città di Torino

D'Avolio A; Marinaro L; Alladio F; Ponzetta L; Cat Genova E; Quaranta M; Stroffolini G; Venuti F; de Nicolò A; Gaviraghi A; Calcagno A;

Association between tight junction proteins and cognitive performance in untreated persons with HIV. in AIDS (London, England) / AIDS. 2024 Jul 15;38(9):1292-1303. doi: 10.1097/QAD.0000000000003923. Epub 2024 May 2.
2024
ASL Città di Torino

Bai F; Bono V; Borghi L; Bonazza F; Falcinella C; Vitaletti V; Miraglia F; Trunfio M; Calcagno A; Cusato J; Vegni E; d'Arminio Monforte A; Marchetti G;

Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV. in AIDS (London, England) / AIDS. 2024 Jul 1;38(8):1273-1275. doi: 10.1097/QAD.0000000000003902. Epub 2024 May 30.
2024
ASL Città di Torino

Trunfio M; Bonora S; di Perri G; Calcagno A;

Central Nervous System Disorders with Auto-Antibodies in People Living with HIV. in Microorganisms / Microorganisms. 2024 Aug 24;12(9):1758. doi: 10.3390/microorganisms12091758.
2024
ASL Città di Torino

Calcagno A; Trunfio M; Di Perri G; Imperiale D; Stroffolini G; Atzori C;

A noma case report: A warning message from Northern Uganda. in Tropical medicine & international health : TM & IH / Trop Med Int Health. 2024 Aug;29(8):752-755. doi: 10.1111/tmi.14025. Epub 2024 Jun 30.
2024
ASL Città di Torino
AOU Città della Salute di Torino

Montrucchio G; Orlotti C; Calcagno A; Ribero S; Smart Okot G; Okao M; Merli M; Achana B; Longo BM;

Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Sep 19;12(9):1460. doi: 10.3390/antibiotics12091460.
2023
ASL Asti
ASL Città di Torino

Calcagno A; Bonora S; De Rosa FG; Gregorc V; Frascione PMM; Allice T; Ponzetta L; Vita D; Pepe A; Lupia T; Ranzani FA; Gaviraghi A; Venuti F; Longo BM;

18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections. in The Journal of infection / J Infect. 2023 Nov;87(5):462-464. doi: 10.1016/j.jinf.2023.03.013. Epub 2023 Mar 17.
2023
ASL Asti
ASL Città di Torino

Aliberti S; Calcagno A; Di Perri G; Lupia T; Sestini S; Erba PA; Betti M; Botto C; Trezzi M; Venuti F; Penna D; Piccioni P; Gaviraghi A; Stroffolini G;

COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Bonora S; Di Perri G; Ferrara M; De Vivo ED; Maiese D; Antonucci M; Chiara F; Costanzo M; Mula J; Manca A; Palermiti A; Cusato J;

COVID-19: A Possible Contribution of the MAPK Pathway. in Biomedicines / Biomedicines. 2023 May 16;11(5):1459. doi: 10.3390/biomedicines11051459.
2023
ASL Città di Torino

De Rosa FG; Di Perri G; Ferrara M; Ianniello A; De Vivo ED; Chiara F; Corcione S; Trunfio M; Antonucci M; Costanzo M; Mula J; Palermiti A; Manca A; Cusato J; D'Avolio A; Calcagno A;

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman. in Virology journal / Virol J. 2023 Jun 13;20(1):123. doi: 10.1186/s12985-023-02086-z.
2023
ASL Città di Torino

Calcagno A; Di Perri G; Fantino S; Alladio F; Burdino E; Allice T; Longo BM; Trevisan G; Ferrara M; Di Girolamo L; Bonora S;

Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Jun;18(1-2):169-182. doi: 10.1007/s11481-023-10066-x. Epub 2023 May 11
2023
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S; Nigra M; Guastamacchia G; Atzori C; Mighetto L; Napoli L; Trunfio M;

2023
ASL Città di Torino

Bonora S; Cinnirella G; D'Avolio A; Marchiaro C; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Longo BM; Stroffolini G; De Nicolò A; Gaviraghi A; Venuti F; Calcagno A;

Extended and Continuous Infusion of Novel Protected ?-Lactam Antibiotics: A Narrative Review. in Drugs / Drugs. 2023 Jul;83(11):967-983. doi: 10.1007/s40265-023-01893-6. Epub 2023 Jun 14.
2023
ASL Città di Torino

Venuti F; Trunfio M; Martson AG; Lipani F; Audagnotto S; Di Perri G; Calcagno A;

Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino

D'Avolio A; Bonora S; Mula J; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Antonucci M; Avataneo V; Cusato J; Calcagno A;

Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood-brain barrier, beta amyloid, and tau proteins in people living with HIV. in Journal of neurovirology / J Neurovirol. 2023 Feb;29(1):100-105. doi: 10.1007/s13365-022-01105-z. Epub 2022 Nov 9.
2023
ASL Città di Torino

Atzori C; Di Perri G; Calcagno A; Imperiale D; Burdino E; Russo M; Di Girolamo L; Ponzetta L; Trunfio M;

The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms? in Autoimmunity reviews / Autoimmun Rev. 2023 Feb;22(2):103237. doi: 10.1016/j.autrev.2022.103237. Epub 2022 Nov 19.
2023
ASL Città di Torino

Sciascia S; Arbrile M; Trunfio M; Calcagno A; Radin M; Roccatello D; Lembo D; Civra A;

Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Dec;18(4):551-562. doi: 10.1007/s11481-023-10086-7. Epub 2023 Oct 31.
2023
ASL Città di Torino

Calcagno A; Di Perri G G; Bonora S; Trunfio M; Nigra M; Atzori C; Giaccone C; Vai D; Pirriatore V; Barco A; Lazzaro A; Stroffolini G;

2023
ASL Città di Torino

Antinori A; Bonora S; Ghisetti V; Focà E; D'Arminio Monforte A; Vera JH; D'Ettorre G; Celani L; Bai F; Arsuffi S; Pinnetti C; Trunfio M; Calcagno A;

A case of histological diagnosis of Toxoplasma gondii myositis in a person living with HIV. in Le infezioni in medicina / Infez Med. 2023 Sep 1;31(3):407-410. doi: 10.53854/liim-3103-16. eCollection 2023.
2023
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino

Corcione S; Calleri G; Calcagno A; De Rosa FG; Cassetta I; Scaglione L; Curtoni A; Mongini TE; Urbano G; Biagini F; De Benedetto I;

2022
ASL Città di Torino

Di Perri G; Calcagno A; Cortese G; Bonora S; Traverso F; Nespoli P; Portesani F; Vicinanza S; Trunfio M;

Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy. in Acta dermato-venereologica / Acta Derm Venereol. 2022 Nov 29;102:adv00821. doi: 10.2340/actadv.v102.1982.
2022
ASL Città di Torino

Mastorino L; Dapavo P; Trunfio M; Avallone G; Rubatto M; Calcagno A; Ribero S; Quaglino P;

2022
ASL Asti
AO Cuneo
ASL Cuneo 1
ASL Città di Torino
ASL Torino 4
AOU San Luigi di Orbassano

Libanore V; Blangetti I; Benedetti V; Scozzari G; Mitola B; Vitale F; Liccardi MM; Chinaglia A; Calcagno A; Bergamo D; Aldieri C; Converso M; Russo ML; Baldassano S; Canta F; Marletto FP; De Micheli AG; Mattei A; Maddalena L; Delios G; Milan M; Baffa A; Russo A; Tornello A; Nucci A; Raso S; Costa C; Pittaluga F; Avolio M; et alii...

Trichinella britovi outbreak in Piedmont, North-West Italy, 2019-2020: Clinical and epidemiological insights in the one health perspective. in Travel medicine and infectious disease / Travel Med Infect Dis. 2022 May-Jun;47:102308. doi: 10.1016/j.tmaid.2022.102308. Epub 2022 Mar 9.
2022
ASL Asti
ASL Città di Torino
ASL Torino 3

Stroffolini G; Calleri G; Di Perri G; Bonora S; Calcagno A; Paltrinieri G; Lipani F; Lupia T; Faraoni S; Rossi L;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;

Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options. in Microorganisms / Microorganisms. 2022 Jun 23;10(7):1275. doi: 10.3390/microorganisms10071275.
2022
ASL Città di Torino
AOU Città della Salute di Torino

Calcagno A; Di Perri G; Bonora S; Rugge W; Scabini S; Trunfio M;

Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV. in AIDS and behavior / AIDS Behav. 2022 Jul;26(7):2203-2211. doi: 10.1007/s10461-021-03563-8. Epub 2022 Jan 4.
2022
ASL Città di Torino

Di Perri G; Calcagno A; Bonora S; Imperiale D; Domini S; Alcantarini C; Milesi M; Medina C; De Francesco D; Vai D; Trunfio M;

Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient. in International journal of STD & AIDS / Int J STD AIDS. 2022 Jan;33(1):94-96. doi: 10.1177/09564624211048343. Epub 2021 Oct 11.
2022
ASL Città di Torino

Parietti M; Trunfio M; Delmonte S; Conti L; Trentalange A; Bonora S; Calcagno A; Ribero S;

2022
ASL Città di Torino

Avataneo V; Palermiti A; De Nicolò A; Cusato J; Giussani G; Calcagno A; D'Avolio A;

Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy. in Annals of work exposures and health / Ann Work Expo Health. 2022 Feb 18;66(2):224-232. doi: 10.1093/annweh/wxab062.
2022
ASL Città di Torino

Airoldi C; Calcagno A; Di Perri G; Valinotto R; Gallo L; Locana E; Trunfio M; Patrucco F; Vineis P; Faggiano F;

The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey. in The new microbiologica / New Microbiol. 2022 Dec;45(4):260-268. Epub 2022 Oct 3.
2022
ASL Città di Torino

Riccardi N; Antonello RM; Giacomelli A; Saderi L; Canetti D; Pallotto C; Mazzaferri F; Degli Antoni AM; Cardellino C; Motta I; Calcagno A; Falcone M; Trezzi M; Comelli A; Pascale R; Merli M; Binda F; Angheben A; Sotgiu G; Gobbi F; Nozza S;

Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. in The Lancet. Respiratory medicine / Lancet Respir Med. 2022 Aug;10(8):785-795. doi: 10.1016/S2213-2600(22)00100-X. Epub 2022 Jun 9.
2022
ASL Città di Torino

Ochoa-Azze R; Chang-Monteagudo A; Climent-Ruiz Y; Macías-Abraham C; Valenzuela-Silva C; de Los Ángeles García-García M; Jerez-Barceló Y; Triana-Marrero Y; Ruiz-Villegas L; Dairon Rodríguez-Prieto L; Guerra-Chaviano PP; Sánchez-Ramírez B; Hernández-García T; Orosa-Vázquez I; Díaz-Hernández M; Chiodo F; Calcagno A; Ghisetti V; Rodríguez-Acosta M; Noa-Romero E; Enríquez-Puertas J; Ortega-León D; Valdivia-Álvarez I; Delahanty-Fernández A; Palenzuela-Díaz A; Rodríguez-Noda L; González-Mugica R; Valdés-Balbín Y; García-Rivera D; et alii...

2022
ASL Città di Torino

Di Perri G; Bonora S; Nigra M; Imperiale D; Vai D; Di Stefano A; Atzori C; Pasquero M; Trunfio M; Calcagno A;

2022
ASL Città di Torino

Bonora S; Trunfio M; Noce G; Atzori C; Guastamacchia G; Vai D; Lazzaro A; Pirriatore V; Stroffolini G; Orlando S; Barco A; Di Perri G; Calcagno A;

Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients. in Brain research bulletin / Brain Res Bull. 2022 Apr;181:129-143. doi: 10.1016/j.brainresbull.2022.01.015. Epub 2022 Jan 29.
2022
ASL Città di Torino

Babiloni C; Del Percio C; Lizio R; Lopez S; Pennica A; Roma P; Correr V; Cucciolla F; Toma G; Soricelli A; Di Campli F; Aceti A; Teti E; Sarmati L; Crocetti G; Ferri R; Lorenzo I; Galli M; Negri C; Angarano G; Saracino A; Lepore L; Di Pietro M; Fusco FM; Vullo V; D'Ettorre G; Pagliano P; Di Flumeri G; Celesia BM; et alii...

Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases. in Frontiers in microbiology / Front Microbiol. 2022 Apr 1;13:829393. doi: 10.3389/fmicb.2022.829393. eCollection 2022.
2022
ASL Città di Torino

Trunfio M; Richiardi L; Alladio F; Staffilano E; Longo B; Venuti F; Ghisetti V; Burdino E; Bonora S; Vineis P; Di Perri G; Calcagno A;

BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors. in Le infezioni in medicina / Infez Med. 2022 Jun 1;30(2):242-246. doi: 10.53854/liim-3002-9. eCollection 2022.
2022
ASL Città di Torino

De Benedetto I; Barco A; Rossi M; Lapadula G; Lupia T; Bonfanti P; Bonora S; Di Perri G; Calcagno A;

Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino

Cusato J; Mula J; Palermiti A; Manca A; Antonucci M; Avataneo V; De Vivo ED; Ianniello A; Calcagno A; Di Perri G; De Nicolò A; D'Avolio A;

2021
ASL Città di Torino

Cusato J; Tempestilli M; Calcagno A; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A;

Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma. in The American journal of tropical medicine and hygiene / Am J Trop Med Hyg. 2021 Oct 11;105(6):1590-1593. doi: 10.4269/ajtmh.21-0630.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Ribero S; Fierro MT; Quaglino P; Senetta R; Caracciolo D; Calcagno A; Merli M; Rubatto M; Mastorino L; Agostini A; Trunfio M; Avallone G;

Alzheimer Dementia in People Living With HIV. in Neurology. Clinical practice / Neurol Clin Pract. 2021 Oct;11(5):e627-e633. doi: 10.1212/CPJ.0000000000001060.
2021
ASL Città di Torino

Di Perri G; Gisslen M; Guaraldi G; d'Ettorre G; Arena V; Imperiale D; Atzori C; Orofino G; Trunfio M; Celani L; Calcagno A;

Serology for Borrelia spp. in Northwest Italy: A Climate-Matched 10-Year Trend. in Life (Basel, Switzerland) / Life (Basel). 2021 Nov 27;11(12):1310. doi: 10.3390/life11121310.
2021
ASL Asti
ASL Città di Torino

Calcagno A; Di Perri G; De Rosa FG; Zanet S; Tomassone L; Rossi L; Faraoni S; Segala FV; Lupia T; Stroffolini G;

2021
ASL Città di Torino

Di Perri G; Bonora S; Emanuele T; Burdino E; Verga F; Ghisetti V; Trunfio M; Calcagno A;

Low cerebrospinal fluid Amyloid-?eta 1-42 in patients with tuberculous meningitis. in BMC neurology / BMC Neurol. 2021 Nov 16;21(1):449. doi: 10.1186/s12883-021-02468-2.
2021
ASL Città di Torino

Calcagno A; Nigra M; Di Stefano A; Di Perri G; Trunfio M; Audagnotto S; Stroffolini G; Atzori C; Guastamacchia G;

2021
ASL Città di Torino

De Nicolò A; Manca A; Ianniello A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;

Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 May 12;11(5):867. doi: 10.3390/diagnostics11050867.
2021
ASL Città di Torino

Calcagno A; Di Perri G; Imperiale D; Bonora S; Atzori C; Nigra M; Cusato J; Ghisetti V; Trunfio M; Caligaris G;

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV. in AIDS (London, England) / AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853.
2021
ASL Città di Torino

Guaraldi G; Calza S; Milic J; Calcagno A; Focà E; Rota M; Renzetti S; Celotti A; Siano M; Celesia BM; Piconi S; de Socio GV; Cattelan AM; Orofino G; Riva A; Nozza S; di Perri G;

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino

Bonora S; Di Perri G; D'Avolio A; Piccioni P; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Motta I; Borgogno E; Trentalange A; Calcagno A;

The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries. in Microorganisms / Microorganisms. 2021 Jul 31;9(8):1648. doi: 10.3390/microorganisms9081648.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Castelnuovo B; Bonora S; Di Perri G; Pirriatore V; Alcantarini C; Rugge W; Mornese Pinna S; Scabini S; Trunfio M; Calcagno A;

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. in The Lancet. Infectious diseases / Lancet Infect Dis. 2021 Jul;21(7):914-915. doi: 10.1016/S1473-3099(21)00205-X. Epub 2021 Apr 14.
2021
ASL Città di Torino

Trunfio M; Calcagno A; Bonora S; Di Perri G;

COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment. in HemaSphere / Hemasphere. 2021 Jun 12;5(7):e592. doi: 10.1097/HS9.0000000000000592. eCollection 2021 Jul.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Rinaldi M; Cavallo R; Stroffolini G; Zanotto E; Barbero C; Ferrero S; Caracciolo D; Boffini M; Ragaini S; Leone S; Grimaldi D; Calcagno A; Dogliotti I; Clerico M; Bruno B; Cavallo F;

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino

Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S; D'Avolio A; Di Perri G;

Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino

Calcagno A; Moltó J; Borghetti A; Gervasoni C; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;

2021
ASL Città di Torino

Di Perri G; Bonora S; Picco C; Bertucci R; Ghisetti V; Cerutti F; Burdino E; Longo BM; Alladio F; Venuti F; Trunfio M; Calcagno A;

Co-infection with other respiratory pathogens in COVID-19 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2021 Feb;27(2):297-298. doi: 10.1016/j.cmi.2020.08.012. Epub 2020 Aug 19.
2021
ASL Città di Torino

Boglione L; Bonora S; Allice T; Trunfio M; Burdino E; Ghisetti V; Calcagno A; Di Perri G; Calcagno A; Ghisetti V; Burdino E; Trunfio M; Allice T; Boglione L; Bonora S; Di Perri G;

On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. in Frontiers in microbiology / Front Microbiol. 2021 Mar 16;12:646679. doi: 10.3389/fmicb.2021.646679. eCollection 2021.
2021
ASL Città di Torino

Trunfio M; Longo BM; Alladio F; Venuti F; Cerutti F; Ghisetti V; Bonora S; Di Perri G; Calcagno A;

Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort. in PloS one / PLoS One. 2021 Oct 13;16(10):e0258533. doi: 10.1371/journal.pone.0258533. eCollection 2021.
2021
ASL Città di Torino

Focà E; Calcagno A; Calza S; Renzetti S; Chiesa A; Siano M; De Socio G; Piconi S; Orofino G; Madeddu G; Cattelan AM; Nozza S; Ferrara M; Milic J; Celesia BM; Castelli F; Guaraldi G;

2020
ASL Città di Torino

Taramasso L; Fabbiani M; Nozza S; De Benedetto I; Bruzzesi E; Mastrangelo A; Pinnetti C; Calcagno A; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; et alii...

A tinea immune reconstitution inflammatory syndrome in a HIV-positive patient starting combination antiretroviral treatment. in Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia / G Ital Dermatol Venereol. 2020 Oct;155(5):695-697. doi: 10.23736/S0392-0488.18.06097-2. Epub 2019 Ja
2020
ASL Città di Torino

Lupia T; Costa C; Forni N; Calcagno A;

A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs. in Journal of neurovirology / J Neurovirol. 2020 Oct;26(5):642-651. doi: 10.1007/s13365-020-00874-9. Epub 2020 Jul 31.
2020
ASL Città di Torino

Calcagno A; Guastamacchia G; Bonora S; Trunfio M; De Benedetto I;

Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1899-1906. doi: 10.1097/QAD.0000000000002601.
2020
ASL Città di Torino

Calcagno A; Di Perri G; Guastamacchia G; Bonora S; Borgogno E; Domini S; Atzori C; Nigra M; Mighetto L; Vai D; Rugge W; Trunfio M;

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino

Sciascia S; Aprà F; Baffa A; Baldovino S; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Cinnirella G; Converso M; Cozzi M; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Giusti M; Imperiale D; Imperiale G; Livigni S; Manno E; Massara C; Milone V; Natale G; Navarra M; Oddone V; Osella S; Piccioni P; et alii...

Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation. in AIDS (London, England) / AIDS. 2020 Mar 1;34(3):373-380. doi: 10.1097/QAD.0000000000002442.
2020
ASL Città di Torino

Di Perri G; Calcagno A; Bonora S; Ghisetti V; Lipani F; Gregori G; Pirriatore V; Mighetto L; Imperiale D; Gianella S; Audagnotto S; Atzori C; Milia MG; Lupia T;

Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2020 Mar;92:62-68. doi: 10.1016/j.ijid.2019.12.031. Epub 2019 Dec 27.
2020
ASL Città di Torino

Goletti D; Navarra A; Petruccioli E; Cimaglia C; Compagno M; Cuzzi G; De Carli G; Fondaco L; Franzetti F; Giannetti A; Gori A; Lapadula G; Lichtner M; Mastroianni CM; Mazzotta V; Orchi N; Pavone P; Piacentini D; Pirriatore V; Pontali E; Sarmati L; Spolti A; Tacconelli E; Galli M; Antinori A; Calcagno A; Girardi E;

2020
ASL Città di Torino

Lamorde M; Di Perri G; Mwaka E; Borderi M; Kafufu B; Cusato J; Kasozi W; Kaimal A; Scabini S; Costa C; Calcagno A; Castelnuovo B;

JC virus DNA in cerebrospinal fluid: insight into clinical significance. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2020 Jun;97(2):115017. doi: 10.1016/j.diagmicrobio.2020.115017. Epub 202
2020
ASL Città di Torino

Imperiale D; Calcagno A; Trunfio M; Mornese Pinna S;

Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study. in CNS spectrums / CNS Spectr. 2020 Jun;25(3):402-408. doi: 10.1017/S1092852919000981. Epub 2019 May 27.
2020
ASL Città di Torino

Calcagno A; Di Perri G; Mighetto L; Milia MG; Audagnotto S; Imperiale D; Burdino E; Atzori C; Lipani F; Alcantarini C; Di Stefano A;

Cerebral white matter Hyperintensities in HIV-positive patients. in Brain imaging and behavior / Brain Imaging Behav. 2020 Feb;14(1):10-18. doi: 10.1007/s11682-018-9966-1.
2020
ASL Città di Torino

Di Perri G; Bonora S; Barco A; Nunnari G; Tettoni M; Imperiale D; Cusato J; Prochet A; Trentalange A; Calcagno A;

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino

De Nicolò A; Ianniello A; Ferrara M; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. in Thrombosis research / Thromb Res. 2020 Dec;196:432-434. doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.
2020
ASL Città di Torino

Bonora S; Roccatello D; Sciascia S; Lipani F; Gaviraghi A; Trentalange A; Marinaro L; Alcantarini C; Cabodi D; Salvador E; Trunfio M; Di Perri G; Calcagno A;

Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. in The pharmacogenomics journal / Pharmacogenomics J. 2020 Apr;20(2):202-212. doi: 10.1038/s41397-019-0109-x. Epub 2019 Oct 16.
2020
ASL Città di Torino

Cusato J; Calcagno A; Marinaro L; Avataneo V; D?Avolio A; Di Perri G; Bonora S;

Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. in Antiviral therapy / Antivir Ther. 2020;25(6):327-333. doi: 10.3851/IMP3377.
2020
ASL Città di Torino

Trunfio M; Salvador E; Gaviraghi A; Audagnotto S; Marinaro L; Motta I; Casciaro R; Ghisetti V; Fava C; Bonora S; Di Perri G; Calcagno A;

2020
ASL Città di Torino

Muscatello A; Nozza S; Fabbiani M; De Benedetto I; Ripa M; Dell'acqua R; Antinori A; Pinnetti C; Calcagno A; Ferrara M; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Maurizio Celesia B; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; D'ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Gori A; et alii...

HIV-1 detection in the olfactory mucosa of HIV-1-infected participants. in AIDS (London, England) / AIDS. 2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102.
2019
ASL Città di Torino

Di Perri G; Calcagno A; Bonora S; Amasio E; Zanusso G; Ghisetti V; Pirriatore V; Kincer LP; Imperiale D; Cassoni P; Catera S; Trunfio M; Allice T; Joseph SB; Bertero L;

Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino

Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort. in Journal of the International AIDS Society / J Int AIDS Soc. 2019 Jan;22(1):e25227. doi: 10.1002/jia2.25227.
2019
ASL Città di Torino

Mondi A; Cozzi-Lepri A; Tavelli A; Rusconi S; Vichi F; Ceccherini-Silberstein F; Calcagno A; De Luca A; Maggiolo F; Marchetti G; Antinori A; d'Arminio Monforte A;

The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes. in Journal of neurovirology / J Neurovirol. 2019 Dec;25(6):887-892. doi: 10.1007/s13365-019-00769-4. Epub 2019 Jun 18.
2019
ASL Città di Torino

Di Perri G; Taraglio S; Bonora S; Imperiale D; Audagnotto S; Boghi A; Trentalange A; Manini C; Trunfio M; Calcagno A;

Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better? in AIDS reviews / AIDS Rev. 2019;21(2):65-75. doi: 10.24875/AIDSRev.19000038.
2019
ASL Città di Torino

Trunfio M; Ribero S; Bonora S; Di Perri G; Quaglino P; Calcagno A;

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort. in PloS one / PLoS One. 2019 Oct 17;14(10):e0222225. doi: 10.1371/journal.pone.0222225. eCollection 2019.
2019
ASL Città di Torino

Focà E; Magro P; Guaraldi G; Riva A; Cattelan AM; De Socio GV; Costa C; Piconi S; Celesia BM; Nozza S; Orofino G; Castagna A; Di Perri G; Castelli F; Calcagno A;

2018
ASL Città di Torino

Di Perri G; Imperiale D; Bonora S; Audagnotto S; Orofino G; Tettoni MC; Livelli A; Alcantarini C; Vai D; Montrucchio C; Trunfio M; Calcagno A;

2018
ASL Città di Torino

Perna M; Cistaro A; Cinnirella G; Ghisetti V; Bertucci R; Audagnotto S; Imperiale D; Pirriatore V; Trunfio M; Scabini S; Calcagno A; Di Perri G;

Precision medicine for HIV: where are we? in Pharmacogenomics / Pharmacogenomics. 2018 Jan;19(2):145-165. doi: 10.2217/pgs-2017-0123. Epub 2017 Dec 5.
2018
ASL Città di Torino

D'Avolio A; Calcagno A; Nicolò A; Allegra S; Cusato J;

2018
ASL Città di Torino

Motta I; Trunfio M; Calcagno A; Pirriatore V; Scabini S; Palazzo A; Audagnotto S; Fatiguso G; Liberini V; Bellò M; D'Avolio A; Di Perri G; Bonora S;

CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose. in Current HIV/AIDS reports / Curr HIV/AIDS Rep. 2018 Feb;15(1):84-91. doi: 10.1007/s11904-018-0375-2.
2018
ASL Città di Torino

Calcagno A; Barco A; Trunfio M; Bonora S;

Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia. in Journal of neurovirology / J Neurovirol. 2018 Feb;24(1):132-136. doi: 10.1007/s13365-017-0605-1. Epub 2017 Dec 14.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Calcagno A; Trunfio M; Imperiale D; Di Perri G; Sala A; Ferrara M; Audagnotto S; Pesci Kincer L; Cusato J; Martini C; Joseph SB; Ghisetti V; Romito A; Trunfio M; Joseph SB; Ghisetti V; Romito A; Martini C; Cusato J; Audagnotto S; Pesci Kincer L; Ferrara M; Sala A; Imperiale D; Di Perri G; Calcagno A;

Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino

Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;

2018
ASL Città di Torino

Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G;

The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. in Antiviral therapy / Antivir Ther. 2018;23(5):451-456. doi: 10.3851/IMP3221.
2018
ASL Città di Torino

Bigliano P; Calcagno A; Lucchini A; Audagnotto S; Montrucchio C; Marinaro L; Alcantarini C; Ghisetti V; Di Perri G; Bonora S;

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2879-2886. doi: 10.1093/jac/dkx169.
2017
ASL Città di Torino

Nozza S; Malagoli A; Maia L; Calcagno A; Focà E; De Socio G; Piconi S; Orofino G; Cattelan AM; Celesia BM; Gervasi E; Guaraldi G;

Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? in Journal of neurovirology / J Neurovirol. 2017 Oct;23(5):763-767. doi: 10.1007/s13365-017-0549-5. Epub 2017 Jul 5.
2017
ASL Città di Torino

Di Perri G; Bonora S; Lipani F; Prochet A; Audagnotto S; Ghisetti V; Imperiale D; Milia MG; Scarvaglieri E; Mornese Pinna S; Calcagno A;

Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2017 Mar;12(1):187-193. doi: 10.1007/s11481-016-9717-2. Epub 2016 Nov 8.
2017
ASL Città di Torino

Di Perri G; Imperiale D; Lipani F; Scarvaglieri E; Audagnotto S; Cardellino C; Ghisetti V; Atzori C; Romito A; Calcagno A; Bonora S;

Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino

Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;

Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):539-544. doi: 10.2459/JCM.0000000000000436.
2017
ASL Città di Torino
AOU Città della Salute di Torino

Mancone M; Ballocca F; Grosso Marra W; Calcagno A; D'Ettorre G; Cannillo M; D'Ascenzo F; Gili S; Orofino G; Marruncheddu L; Lonni E; Cinque A; Vullo F; Ceccarelli G; Vilardi I; Sardella G; Vullo V; Moretti C; Fedele F; Bonora S; Gaita F;

Treating HIV Infection in the Central Nervous System. in Drugs / Drugs. 2017 Feb;77(2):145-157. doi: 10.1007/s40265-016-0678-9.
2017
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S;

Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.
2017
ASL Città di Torino

Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;

Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs. in Clinical pharmacokinetics / Clin Pharmacokinet. 2017 Apr;56(4):355-369. doi: 10.1007/s40262-016-0456-6.
2017
ASL Città di Torino

Calcagno A; Cusato J; D'Avolio A; Bonora S;

Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. in Antiviral therapy / Antivir Ther. 2017;22(6):539-543. doi: 10.3851/IMP3140. Epub 2017 Feb 15.
2017
ASL Città di Torino

Bonora S; Di Perri G; Ghisetti V; Imperiale D; Ecclesia S; Ferrara M; Romito A; Allice T; Motta I; Calcagno A;

High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders. in Current HIV research / Curr HIV Res. 2017;15(4):258-265. doi: 10.2174/1570162X15666170531085838.
2017
ASL Città di Torino

Calcagno A; Lucchini A; Caracciolo D; Balbiano R; Bracchi M; Sordella F; Gregori G; Lipani F; Audagnotto S; Chiriotto M; Cavaglia G; Ghisetti V; Di Perri G; Bonora S;

HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era. in Progress in cardiovascular diseases / Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):565-76. doi: 10.1016/j.pcad.2016.02.008. Epub 2016 Mar 2.
2016
ASL Città di Torino
AOU Città della Salute di Torino

Moretti C; Coppola J; Bonora S; Flammer A; Calcagno A; Cannillo M; Marra WG; D'Ascenzo F; Gili S; Ballocca F; Gaita F;

Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study. in International journal of pharmaceutics / Int J Pharm. 2016 Jan 30;497(1-2):287-92. doi: 10.1016/j.ijpharm.2015.11.044. Epub 2015 Nov 28.
2016
ASL Città di Torino

Bonora S; Perri GD; Cusato J; Favata F; Motta I; Baietto L; Calcagno A; Allegra S; Fatiguso G; D'Avolio A;

Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino

Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A; Cusato J; Tomasello C; Simiele M; Calcagno A; Bonora S; Marinaro L; Leggieri A; Allegra S; Di Perri G; D'Avolio A;

Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. in Journal of neurovirology / J Neurovirol. 2016 Feb;22(1):88-92. doi: 10.1007/s13365-015-0371-x. Epub 2015 Aug 6.
2016
ASL Città di Torino

Di Perri G; Imperiale D; Montrucchio C; Stella ML; Vai D; Audagnotto S; Romito A; Atzori C; Calcagno A; Bonora S; Calcagno A; Atzori C; Romito A; Vai D; Audagnotto S; Stella ML; Montrucchio C; Imperiale D; Di Perri G; Bonora S;

Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis. in European heart journal / Eur Heart J. 2016 Dec 21;37(48):3600-3609. doi: 10.1093/eurheartj/ehv734. Epub 2016 Feb 6.
2016
ASL Città di Torino
AOU Città della Salute di Torino

Gasparini M; Bonora S; Omedè P; Montefusco A; Lavie CJ; DiNicolantonio JJ; Mancone M; Barbero U; Pianelli M; Cerrato E; Ballocca F; Cannillo M; Calcagno A; Lonni E; D'Ascenzo F; Grosso Marra W; Gili S; Biondi-Zoccai G; Moretti C; Gaita F; Gili S; Grosso Marra W; D'Ascenzo F; Lonni E; Calcagno A; Cannillo M; Ballocca F; Cerrato E; Pianelli M; et alii...

HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testing. in Infection / Infection. 2016 Dec;44(6):789-792. doi: 10.1007/s15010-016-0937-4. Epub 2016 Aug 13.
2016
ASL Città di Torino

Ruggiero T; Burdino E; Calcagno A; Bonora S; Boglione L; Di Perri G; Ghisetti V;

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. in Current HIV research / Curr HIV Res. 2016;14(1):54-60. doi: 10.2174/1570162x13666150929112135.
2016
ASL Città di Torino

Calcagno A; Montrucchio C; Capetti A; Guaraldi G; Cenderello G; Calza L; Lanzafame M; Marinaro L; Tettoni MC; Trentini L; D'Avolio A; Di Perri G; Bonora S;

Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. in Antiviral therapy / Antivir Ther. 2016;21(7):633-635. doi: 10.3851/IMP3032. Epub 2016 Feb 9.
2016
ASL Città di Torino

Bonora S; Busolli P; Atzori C; Ghisetti V; Calcagno A; Trentalange A; Imperiale D;

A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Sep;70(9):2572-5. doi: 10.1093/jac/dkv148. Epub 2015 Jun 11.
2015
ASL Città di Torino

Baietto L; Calcagno A; Motta I; Baruffi K; Poretti V; Di Perri G; Bonora S; D'Avolio A;

A LC-MS method to quantify tenofovir urinary concentrations in treated patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:8-11. doi: 10.1016/j.jpba.2015.05.001. Epub 2015 May 8.
2015
ASL Città di Torino

Simiele M; Carcieri C; De Nicolò A; Ariaudo A; Sciandra M; Calcagno A; Bonora S; Di Perri G; D'Avolio A;

Erratum to: Ageing with HIV: a multidisciplinary review. in Infection / Infection. 2015 Oct;43(5):627. doi: 10.1007/s15010-015-0808-4.
2015
ASL Città di Torino

Calcagno A; Nozza S; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G;

Ageing with HIV: a multidisciplinary review. in Infection / Infection. 2015 Oct;43(5):509-22. doi: 10.1007/s15010-015-0795-5. Epub 2015 May 19.
2015
ASL Città di Torino

Calcagno A; Nozza S; Muss C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G;

2015
ASL Città di Torino

Andreoni M; Marcotullio S; Puro V; De Carli G; Tambussi G; Nozza S; Gori A; Rusconi S; Santoro MM; Clementi M; Perno CF; d'Arminio Monforte A; Maggiolo F; Castagna A; De Luca A; Galli M; Giacomelli A; Borderi M; Guaraldi G; Calcagno A; Di Perri G; Bonora S; Mussini C; Di Biagio A; Puoti M; Bruno R; Zuccaro V; Antinori A; Cinque P; et alii...

HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients. in AIDS research and human retroviruses / AIDS Res Hum Retroviruses. 2015 Oct;31(10):999-1008. doi: 10.1089/AID.2015.0102. Epub 2015 Aug 6.
2015
ASL Città di Torino

Calcagno A; Motta I; Ghisetti V; Lo Re S; Allice T; Marinaro L; Milia MG; Tettoni MC; Trentini L; Orofino G; Salassa B; Di Perri G; Bonora S;

Class-specific relative genetic contribution for key antiretroviral drugs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Nov;70(11):3074-9. doi: 10.1093/jac/dkv207. Epub 2015 Jul 28.
2015
ASL Città di Torino

Siccardi M; Olagunju A; Simiele M; D'Avolio A; Calcagno A; Di Perri G; Bonora S; Owen A;

High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis. in Atherosclerosis / Atherosclerosis. 2015 May;240(1):197-204. doi: 10.1016/j.atherosclerosis.2015.03.019. Epub 2015 Mar
2015
ASL Città di Torino

D'Ascenzo F; Cerrato E; Calcagno A; Grossomarra W; Ballocca F; Omedè P; Montefusco A; Veglia S; Barbero U; Gili S; Cannillo M; Pianelli M; Mistretta E; Raviola A; Salera D; Garabello D; Mancone M; Estrada V; Escaned J; De Marie D; Abbate A; Bonora S; Zoccai GB; Moretti C; Gaita F;

Heart failure in patients with human immunodeficiency virus: a review of the literature. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2015 May;16(5):383-9. doi: 10.2459/JCM.0000000000000168.
2015
ASL Città di Torino

Cannillo M; D'Ascenzo F; Grosso Marra W; Cerrato E; Calcagno A; Omedè P; Bonora S; Mancone M; Vizza D; DiNicolantonio JJ; Pianelli M; Barbero U; Gili S; Annone U; Raviola A; Salera D; Mistretta E; Vilardi I; Colaci C; Abbate A; Zoccai GB; Moretti C; Gaita F;

Pharmacokinetic and pharmacodynamic evaluation of raltegravir and experience from clinical trials in HIV-positive patients. in Expert opinion on drug metabolism & toxicology / Expert Opin Drug Metab Toxicol. 2015 Jul;11(7):1167-76. doi: 10.1517/17425255.2015.1056732.
2015
ASL Città di Torino

Calcagno A; D'Avolio A; Bonora S;

Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Jan;70(1):307-8. doi: 10.1093/jac/dku368. Epub 2014 Sep 18.
2015
ASL Città di Torino

Baietto L; D'Avolio A; Cusato J; Pace S; Calcagno A; Motta I; Corcione S; Di Perri G; De Rosa FG;

Acute HIV infection: improved algorithms for HIV testing. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2015 Feb;63:51-2. doi: 10.1016/j.jcv.2014.12.007. Epub 2014 Dec 12.
2015
ASL Città di Torino

Ghisetti V; Calcagno A; Burdino E; Orofino G; Bonora S;

Cardiovascular disease in HIV patients: from bench to bedside and backwards. in Open heart / Open Heart. 2015 Mar 20;2(1):e000174. doi: 10.1136/openhrt-2014-000174. eCollection 2015.
2015
ASL Città di Torino

Cerrato E; Calcagno A; D'Ascenzo F; Biondi-Zoccai G; Mancone M; Grosso Marra W; Demarie D; Omedè P; Abbate A; Bonora S; DiNicolantonio JJ; Estrada V; Escaned J; Moretti C; Gaita F;

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Sep;69(9):2586-8. doi: 10.1093/jac/dku142. Epub 2014 May 8.
2014
ASL Città di Torino

Calcagno A; Nozza S; Simiele M; Milia MG; Chiappetta S; D'Avolio A; Ghisetti V; Lazzarin A; Di Perri G; Bonora S;

2014
ASL Città di Torino
AOU Città della Salute di Torino

DiNicolantonio JJ; Omedè P; Fedele F; Sardella G; Vignali L; Mancone M; Manga P; Vachiat A; Parodi G; Santilli F; Tamburino C; Capodanno D; Belli R; Chinaglia A; Cassese S; Kastrati A; Escaned J; Das Neves B; Carrie D; Lhermusier T; Abouzaki N; Vetrovec G; Calcagno A; Moretti C; Appleton D; Cerrato E; D'Ascenzo F; Bonora S; Gaita F; et alii...

Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system. in Clinical pharmacokinetics / Clin Pharmacokinet. 2014 Oct;53(10):891-906. doi: 10.1007/s40262-014-0171-0.
2014
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S;

Prevalence and predictors of blood-brain barrier damage in the HAART era. in Journal of neurovirology / J Neurovirol. 2014 Oct;20(5):521-5. doi: 10.1007/s13365-014-0266-2. Epub 2014 Jun 28.
2014
ASL Città di Torino

Calcagno A; Alberione MC; Romito A; Imperiale D; Ghisetti V; Audagnotto S; Lipani F; Raviolo S; Di Perri G; Bonora S;

Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Nov;69(11):3061-6. doi: 10.1093/jac/dku234. Epub 2014 Jul 4.
2014
ASL Città di Torino

D'Avolio A; Carcieri C; Cusato J; Simiele M; Calcagno A; Allegra S; Sciandra M; Trentini L; Di Perri G; Bonora S;

Healthcare-associated Klebsiella pneumoniae carbapenemase producing K. pneumoniae bloodstream infection: the time has come. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2014 Jul 15;59(2):321-2. doi: 10.1093/cid/ciu294. Epub 2014 Apr 24.
2014
ASL Città di Torino

Corcione S; Cardellino CS; Calcagno A; Fossati L; Costa C; Cavallo R; Di Perri G; De Rosa FG;

Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimens. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2014 Jul;58(7):4042-7. doi: 10.1128/AAC.00104-14. Epub 2014 May 5.
2014
ASL Città di Torino

De Nicolò A; Simiele M; Calcagno A; Abdi AM; Bonora S; Di Perri G; D'Avolio A;

Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction. in Pharmacogenomics / Pharmacogenomics. 2014 Jul;15(10):1281-6. doi: 10.2217/pgs.14.92.
2014
ASL Città di Torino

Calcagno A; Baietto L; Pagani N; Simiele M; Audagnotto S; D'Avolio A; De Rosa FG; Di Perri G; Bonora S;

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients. in Antiviral research / Antiviral Res. 2014 Aug;108:44-7. doi: 10.1016/j.antiviral.2014.05.009. Epub 2014 May 23.
2014
ASL Città di Torino

Calcagno A; Marinaro L; Nozza S; Aldieri C; Carbone A; Ghisetti V; Trentalange A; D'Avolio A; Castagna A; Di Perri G; Bonora S;

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19719. doi: 10.7448/IAS.17.4.19719. eCollection 2014.
2014
ASL Città di Torino

Calcagno A; Atzori C; Romito A; Ecclesia S; Imperiale D; Audagnotto S; Alberione MC; Trentalange A; Di Perri G; Bonora S;

Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients. in Current HIV research / Curr HIV Res. 2014;12(5):339-46. doi: 10.2174/1570162x12666140807151616.
2014
ASL Città di Torino

Bonora S; Calcagno A; Vigano O; Bigliano P; Marinaro L; Colella E; Orofino G; Trentini L; Tettoni MC; D'Avolio A; Mercadante S; Galli M; Di Perri G; Rusconi S;

A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection. in Influenza and other respiratory viruses / Influenza Other Respir Viruses. 2013 Nov;7(6):1416-26. doi: 10.1111/irv.12146. Epub 2013 Aug 9.
2013
ASL Città di Torino

Ruggiero T; De Rosa F; Cerutti F; Pagani N; Allice T; Stella ML; Milia MG; Calcagno A; Burdino E; Gregori G; Urbino R; Di Perri G; Ranieri MV; Ghisetti V;

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2013 Apr;68(4):907-10. doi: 10.1093/jac/dks484. Epub 2012 Dec 5.
2013
ASL Città di Torino

D'Avolio A; Simiele M; Calcagno A; Siccardi M; Larovere G; Agati S; Baietto L; Cusato J; Tettoni M; Sciandra M; Trentini L; Di Perri G; Bonora S;

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Jul;66:376-80. doi: 10.1016/j.jpba.2012.03.030. Epub 2012 Mar 28.
2012
ASL Città di Torino

D'Avolio A; De Nicolò A; Simiele M; Turini S; Agnesod D; Boglione L; Cusato J; Baietto L; Cariti G; Calcagno A; Sciandra M; Di Perri G; Bonora S;

2012
ASL Città di Torino

Bonora S; Calcagno A; Cometto C; Fontana S; Aguilar D; D'Avolio A; Gonzalez de Requena D; Maiello A; Dal Conte I; Lucchini A; Di Perri G;

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. in Therapeutic drug monitoring / Ther Drug Monit. 2012 Dec;34(6):722-8. doi: 10.1097/FTD.0b013e318272e55a.
2012
ASL Città di Torino

D'Avolio A; Ciancio A; Siccardi M; Smedile A; Simiele M; Cusato J; Baietto L; Aguilar Marucco D; Cariti G; Calcagno A; Gonzalez de Requena D; Sciandra M; Troshina G; Caviglia GP; Bonora S; Rizzetto M; Di Perri G;

2012
ASL Città di Torino

D?Avolio A; Ciancio A; Siccardi M; Smedile A; Baietto L; Simiele M; Marucco DA; Cariti G; Calcagno A; de Requena DG; Sciandra M; Cusato J; Troshina G; Bonora S; Rizzetto M; Di Perri G;

2011
ASL Città di Torino

Bonora S; Gonzalez de Requena D; D'Avolio A; Calcagno A; Tettoni M; Siccardi M; Baietto L; Simiele M; Trentini L; Di Perri G;

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2010 Dec;20(12):759-65. doi: 10.1097/FPC.0b013e3283402efb.
2010
ASL Città di Torino

Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan WS; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;

Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. in The Journal of infection / J Infect. 2008 Jul;57(1):78-81. doi: 10.1016/j.jinf.2008.05.005. Epub 2008 Jun 11.
2008
ASL Città di Torino

Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G;

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2007 Mar;59(3):565-8. doi: 10.1093/jac/dkl497. Epub 2007 Jan 9.
2007
ASL Città di Torino

Aguilar Marucco D; Veronese L; de Requena DG; Bonora S; Calcagno A; Cavecchia I; Sinicco A; De Rosa FG; Cariti G; Di Perri G;